Patients Are the “Value” Focus in Cancer Care, Panelists Agree
April 9th 2021There are many sources, and definitions, of where the value in cancer care lies. In this panel discussion, a cancer survivor and patient advocate, an oncologist, and a benefits professional provided their perspectives on what value in cancer care means to them.
Read More
Dr Lalan Wilfong Discusses Growth in Remote Monitoring, Future of Value-Based Cancer Care
April 9th 2021Lalan Wilfong, MD, executive vice president, Value Based Care & Quality Programs, Texas Oncology, and cochair, Payment Reform, Community Oncology Alliance, speaks on the evolution of remote monitoring in cancer care and how value-based oncology may look in the near future.
Read More
Dr Edward Licitra on Aligning Patient, Physician Goals in Value-Based Cancer Care
April 9th 2021Edward Licitra, MD, PhD, medical oncologist, Astera Health Partners, discusses his thoughts on what value-based cancer care entails and how physicians can best align their goals with those of the patient and health plan.
Read More
Palliative Care Encompasses Much More Than End-of-Life Care
April 8th 2021A popular misconception of palliative care is that it only has importance toward making patients comfortable at the end of their lives, noted a palliative care physician on the first day of the 2021 Community Oncology Conference, presented by the Community Oncology Alliance.
Read More
Lalan Wilfong, MD, executive vice president, Value Based Care & Quality Programs, Texas Oncology, and co-chair, Payment Reform, Community Oncology Alliance, discusses implications of quality metrics in cancer care and what perspectives on the topic he is looking forward to hearing at the 2021 Community Oncology Conference.
Read More
Dr Dinesh Kapur Addresses Cancer Care Disparities Ahead of the 2021 Community Oncology Conference
April 3rd 2021Dinesh Kapur, MD, chair, OneCouncil, and managing partner, Eastern Connecticut Hematology and Oncology (ECHO), speaks on efforts made by by community oncology practices to improve minority representation in oncology clinical trials and implications of the COVID-19 pandemic ahead of the 2021 Community Oncology Conference.
Read More
Kathy Oubre Previews Biosimilar Discussion at the 2021 Community Oncology Alliance
April 1st 2021Kathy Oubre, MS, chief operating officer, Pontchartrain Cancer Center, explores US adoption of biosimilars ahead of her panel discussion at the 2021 Community Oncology Conference, as well as what sessions she’s looking forward to attending.
Read More
Bo Gamble on Keynote Sessions, Potential Takeaways of Community Oncology Conference 2021
March 30th 2021Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, highlights his questions for the keynote speakers of the 2021 Community Oncology Conference, and takeaways he hopes audience members gain from the sessions.
Read More
Ted Okon Discusses How COA Members Responded to Challenges of COVID-19
March 28th 2021Ted Okon, MBA, executive director, Community Oncology Alliance (COA), speaks on the most significant challenges members encountered in the past year managing the COVID-19 pandemic ahead of the 2021 Community Oncology Conference.
Read More
Dr Jeff Patton on Notable Sessions, What to Expect at Community Oncology Conference 2021
March 26th 2021Jeff Patton, MD, CEO, OneOncology, chairman of the board, Tennessee Oncology, discusses what audience members should expect from the Community Oncology Conference 2021 and sessions he is looking forward to.
Read More
Dr Lalan Wilfong Talks Employer Involvement in Cancer Care Benefits
October 28th 2020Lalan Wilfong, MD, executive vice president for quality programs and value-based care at Texas Oncology and Community Oncology Alliance payment reform co-chair, discusses the role of employers in cancer care benefits and issues stemming from the pandemic.
Read More
Defining Quality, Value in Cancer Care: What Employers Should Seek From Providers
October 28th 2020A panel of key opinion leaders discuss how employers and self-funded companies should assess provider quality and value in cancer care at the 2020 Community Oncology Alliance Virtual Payer Exchange Summit.
Read More
Cancer Does Not Stop for COVID-19, but Reform Becomes a Challenge
October 28th 2020During a session on day 1 of the Community Oncology Alliance (COA) Virtual Payer Exchange Summit on Oncology Payment Reform, a panel of experts discussed the ways COVID-19 continues to impact cancer care and payment reform.
Read More
Dr Barbara McAneny on Issues With Step Therapy and Home Infusion in Oncology
October 27th 2020Barbara McAneny, MD, founding partner of New Mexico Oncology Hematology Consultants, discusses the challenges in care delivery with step therapy in Medicare Advantage and much-debated home infusion in oncology.
Read More
Dr Lucio Gordan on Telehealth and New Care Initiatives in COVID-19
October 27th 2020Lucio Gordan, MD, president and managing physician at Florida Cancer Specialists and Research Institute, discusses the impact that COVID-19 continues to have on health care delivery and payment reform initiatives as the COA Payer Exchange Summit tackles this and other issues in payment reform.
Read More
Bo Gamble Discusses Themes in Oncology Care Reform Ahead of COA Payer Exchange Summit
October 26th 2020Bo Gamble, director of Strategic Practice Initiatives for the Community Oncology Alliance (COA), previewed the COA Payer Exchange Summit on Oncology Payment Reform ahead of the 2-day virtual meeting on October 27-28, 2020.
Read More
Dr Mark Fendrick Previews VBID Panel Discussion at COA Payer Exchange Summit
October 26th 2020During the upcoming Community Oncology Alliance (COA) Payer Exchange Summit, a panel discussion on applying value-based insurance design (VBID) in oncology will explore ways in which the coronavirus disease 2019 crisis can be an opportunity for growth.
Read More
PBMs and Community Oncology: "We Just Can't Let Them Get Away With What They're Doing"
April 25th 2020Despite the immediate distraction from coronavirus disease 2019 (COVID-19), panelists at the 2020 Virtual Community Oncology Conference said community oncologists must keep pressure on pharmacy benefit managers (PBMs) as the 2020 campaign heats up—lest they lose the momentum to rein PBM practices within the umbrella of drug pricing reform.
Read More
COA Consensus: Telemedicine Is Here to Stay, but Practice Transformation Could Stall
April 25th 2020The bright spot of telemedicine's success during the coronavirus disease 2019 pandemic cannot overshadow the stresses on patients and practices, which will both have ongoing challenges when the pandemic ends, said panelists during a legislative update on day 2 of the 2020 Virtual Community Oncology Conference, convened by the Community Oncology Alliance.
Read More